| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.057 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |